Romain Guilhaumou
Romain Guilhaumou
Pharmacologie, APHM
Verified email at
Cited by
Cited by
Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de …
R Guilhaumou, S Benaboud, Y Bennis, C Dahyot-Fizelier, E Dailly, ...
Critical Care 23 (1), 1-20, 2019
Inflammation is a major regulator of drug metabolizing enzymes and transporters: consequences for the personalization of drug treatment
F Stanke-Labesque, E Gautier-Veyret, S Chhun, R Guilhaumou, ...
Pharmacology & therapeutics 215, 107627, 2020
Amikacin in critically ill patients: a review of population pharmacokinetic studies
A Marsot, R Guilhaumou, C Riff, O Blin
Clinical pharmacokinetics 56, 127-138, 2017
Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity
R Guilhaumou, C Solas, V Bourgarel-Rey, S Quaranta, A Rome, N Simon, ...
Cancer chemotherapy and pharmacology 68, 1633-1638, 2011
Validation of an electrospray ionization LC/MS/MS method for quantitative analysis of vincristine in human plasma samples
R Guilhaumou, C Solas, A Rome, M Giocanti, N Andre, B Lacarelle
Journal of Chromatography B 878 (3-4), 423-427, 2010
Chloroquine and hydroxychloroquine in the management of COVID-19: much kerfuffle but little evidence
M Roustit, R Guilhaumou, M Molimard, MD Drici, S Laporte, JL Montastruc, ...
Therapies 75 (4), 363-370, 2020
Population pharmacokinetics and pharmacogenetics of vincristine in paediatric patients treated for solid tumour diseases
R Guilhaumou, N Simon, S Quaranta, A Verschuur, B Lacarelle, N Andre, ...
Cancer chemotherapy and pharmacology 68, 1191-1198, 2011
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection
N Venisse, G Peytavin, S Bouchet, MC Gagnieu, R Garraffo, ...
Antiviral Research 181, 104866, 2020
Pediatric patients with solid or hematological tumor disease: vancomycin population pharmacokinetics and dosage optimization
R Guilhaumou, A Marsot, J Dupouey, C Galambrun, A Boulamery, C Coze, ...
Therapeutic drug monitoring 38 (5), 559-566, 2016
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT)
F Lemaitre, M Grégoire, C Monchaud, S Bouchet, B Saint-Salvi, E Polard, ...
Therapies 77 (5), 509-521, 2022
Effects of hydroxychloroquine on Covid-19 in intensive care unit patients: preliminary results
A Lopez, G Duclos, B Pastene, K Bezulier, R Guilhaumou, C Solas, ...
International journal of antimicrobial agents 56 (5), 106136, 2020
Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection
P Giaime, M Guenoun, N Pedinielli, H Narbonne, JP Bergounioux, ...
Nephrology Dialysis Transplantation 35 (8), 1346-1353, 2020
Levodopa in Parkinson’s disease: a review of population pharmacokinetics/pharmacodynamics analysis
A Marsot, R Guilhaumou, JP Azulay, O Blin
Journal of Pharmacy & Pharmaceutical Sciences 20, 226-238, 2017
Simultaneous determination of four antiepileptic drugs in human plasma samples using an ultra‐high‐performance liquid chromatography tandem mass spectrometry method and its …
J Dupouey, N Doudka, S Belo, O Blin, R Guilhaumou
Biomedical Chromatography 30 (12), 2053-2060, 2016
French Society of Pharmacology and Therapeutics Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug …
F Stanke-Labesque, E Gautier-Veyret, S Chhun, R Guilhaumou
Pharmacol. Ther 215, 107627, 2020
External evaluation of population pharmacokinetic models for continuous administration of meropenem in critically ill adult patients
YL Wang, R Guilhaumou, O Blin, L Velly, A Marsot
European Journal of Clinical Pharmacology 76, 1281-1289, 2020
Population pharmacokinetics of rifampicin in adult patients with osteoarticular infections: interaction with fusidic acid
A Marsot, A Ménard, J Dupouey, C Muziotti, R Guilhaumou, O Blin
British journal of clinical pharmacology 83 (5), 1039-1047, 2017
Serious neurological adverse events of ceftriaxone
C Lacroix, AP Bera-Jonville, F Montastruc, L Velly, J Micallef, ...
Antibiotics 10 (5), 540, 2021
Suivi thérapeutique pharmacologique du 5-fluorouracile: mise au point et recommandations du groupe STP-PT de la SFPT et du GPCO-Unicancer
F Lemaitre, F Goirand, M Launay, E Chatelut, JC Boyer, A Evrard, ...
Bulletin du Cancer 105 (9), 790-803, 2018
Intrapleural administration of lipoplatin in an animal model
ME Froudarakis, L Greillier, S Monjanel-Mouterde, A Koutsopoulos, ...
Lung Cancer 72 (1), 78-83, 2011
The system can't perform the operation now. Try again later.
Articles 1–20